nodes	percent_of_prediction	percent_of_DWPC	metapath
Bleomycin—LIG1—urinary bladder cancer	0.474	1	CbGaD
Bleomycin—testicular cancer—urinary bladder cancer	0.35	1	CtDrD
Bleomycin—LIG3—Resolution of AP sites via the single-nucleotide replacement pathway—POLB—urinary bladder cancer	0.00922	0.146	CbGpPWpGaD
Bleomycin—LIG3—Base Excision Repair—POLB—urinary bladder cancer	0.00638	0.101	CbGpPWpGaD
Bleomycin—LIG3—Resolution of AP sites via the single-nucleotide replacement pathway—XRCC1—urinary bladder cancer	0.0057	0.0903	CbGpPWpGaD
Bleomycin—LIG3—Base Excision Repair—LIG1—urinary bladder cancer	0.00431	0.0683	CbGpPWpGaD
Bleomycin—LIG3—Base Excision Repair—XRCC1—urinary bladder cancer	0.00394	0.0625	CbGpPWpGaD
Bleomycin—LIG3—prostate gland—urinary bladder cancer	0.00361	0.104	CbGeAlD
Bleomycin—LIG1—prostate gland—urinary bladder cancer	0.00334	0.0959	CbGeAlD
Bleomycin—LIG1—seminal vesicle—urinary bladder cancer	0.00282	0.0811	CbGeAlD
Bleomycin—LIG1—Removal of DNA patch containing abasic residue—POLB—urinary bladder cancer	0.00271	0.0429	CbGpPWpGaD
Bleomycin—BLMH—prostate gland—urinary bladder cancer	0.0027	0.0774	CbGeAlD
Bleomycin—LIG3—epithelium—urinary bladder cancer	0.00265	0.0761	CbGeAlD
Bleomycin—LIG1—Base Excision Repair—POLB—urinary bladder cancer	0.00248	0.0392	CbGpPWpGaD
Bleomycin—LIG3—renal system—urinary bladder cancer	0.00246	0.0706	CbGeAlD
Bleomycin—BLMH—seminal vesicle—urinary bladder cancer	0.00228	0.0655	CbGeAlD
Bleomycin—LIG3—female reproductive system—urinary bladder cancer	0.00197	0.0566	CbGeAlD
Bleomycin—BLMH—renal system—urinary bladder cancer	0.00184	0.0528	CbGeAlD
Bleomycin—LIG1—female reproductive system—urinary bladder cancer	0.00182	0.0523	CbGeAlD
Bleomycin—BLMH—urethra—urinary bladder cancer	0.0018	0.0518	CbGeAlD
Bleomycin—LIG1—vagina—urinary bladder cancer	0.00165	0.0473	CbGeAlD
Bleomycin—LIG3—DNA Repair—FANCA—urinary bladder cancer	0.00153	0.0243	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—POLB—urinary bladder cancer	0.00153	0.0243	CbGpPWpGaD
Bleomycin—LIG1—Base Excision Repair—XRCC1—urinary bladder cancer	0.00153	0.0242	CbGpPWpGaD
Bleomycin—BLMH—female reproductive system—urinary bladder cancer	0.00147	0.0423	CbGeAlD
Bleomycin—BLMH—vagina—urinary bladder cancer	0.00133	0.0382	CbGeAlD
Bleomycin—LIG3—lymph node—urinary bladder cancer	0.00115	0.0331	CbGeAlD
Bleomycin—LIG1—Global Genomic NER (GG-NER)—ERCC4—urinary bladder cancer	0.00108	0.0171	CbGpPWpGaD
Bleomycin—LIG1—lymph node—urinary bladder cancer	0.00107	0.0306	CbGeAlD
Bleomycin—LIG3—DNA Repair—ERCC4—urinary bladder cancer	0.00106	0.0168	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—LIG1—urinary bladder cancer	0.00104	0.0164	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—XRCC1—urinary bladder cancer	0.000947	0.015	CbGpPWpGaD
Bleomycin—LIG1—Transcription-coupled NER (TC-NER)—ERCC4—urinary bladder cancer	0.000861	0.0136	CbGpPWpGaD
Bleomycin—BLMH—lymph node—urinary bladder cancer	0.000861	0.0247	CbGeAlD
Bleomycin—LIG1—Nucleotide Excision Repair—ERCC4—urinary bladder cancer	0.000792	0.0125	CbGpPWpGaD
Bleomycin—LIG1—Podofilox—Etoposide—urinary bladder cancer	0.000774	0.504	CbGdCrCtD
Bleomycin—BLMH—Antigen processing: Ubiquitination & Proteasome degradation—VHL—urinary bladder cancer	0.000713	0.0113	CbGpPWpGaD
Bleomycin—LIG1—Homologous Recombination Repair—ATM—urinary bladder cancer	0.000682	0.0108	CbGpPWpGaD
Bleomycin—BLMH—Class I MHC mediated antigen processing & presentation—VHL—urinary bladder cancer	0.000612	0.00969	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—POLB—urinary bladder cancer	0.000595	0.00943	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—FANCA—urinary bladder cancer	0.000595	0.00943	CbGpPWpGaD
Bleomycin—LIG1—Double-Strand Break Repair—ATM—urinary bladder cancer	0.000536	0.00849	CbGpPWpGaD
Bleomycin—LIG1—Extension of Telomeres—TERT—urinary bladder cancer	0.000495	0.00785	CbGpPWpGaD
Bleomycin—LIG1—Global Genomic NER (GG-NER)—ERCC2—urinary bladder cancer	0.000465	0.00737	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—ERCC2—urinary bladder cancer	0.000459	0.00727	CbGpPWpGaD
Bleomycin—BLMH—Azacitidine—Gemcitabine—urinary bladder cancer	0.000449	0.292	CbGdCrCtD
Bleomycin—LIG1—DNA Repair—ERCC4—urinary bladder cancer	0.000412	0.00653	CbGpPWpGaD
Bleomycin—BLMH—Antigen processing: Ubiquitination & Proteasome degradation—RBX1—urinary bladder cancer	0.00041	0.00649	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—ATM—urinary bladder cancer	0.000387	0.00613	CbGpPWpGaD
Bleomycin—LIG1—S Phase—STAG2—urinary bladder cancer	0.000375	0.00595	CbGpPWpGaD
Bleomycin—LIG1—Transcription-coupled NER (TC-NER)—ERCC2—urinary bladder cancer	0.000372	0.00589	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—XRCC1—urinary bladder cancer	0.000367	0.00582	CbGpPWpGaD
Bleomycin—BLMH—Class I MHC mediated antigen processing & presentation—RBX1—urinary bladder cancer	0.000351	0.00557	CbGpPWpGaD
Bleomycin—LIG1—Nucleotide Excision Repair—ERCC2—urinary bladder cancer	0.000342	0.00542	CbGpPWpGaD
Bleomycin—LIG1—Azacitidine—Gemcitabine—urinary bladder cancer	0.000312	0.203	CbGdCrCtD
Bleomycin—BLMH—Adaptive Immune System—VHL—urinary bladder cancer	0.000303	0.0048	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—SMC1B—urinary bladder cancer	0.000295	0.00467	CbGpPWpGaD
Bleomycin—LIG1—S Phase—SMC1A—urinary bladder cancer	0.000263	0.00417	CbGpPWpGaD
Bleomycin—LIG1—Telomere Maintenance—TERT—urinary bladder cancer	0.000224	0.00356	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000201	0.00319	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.0002	0.00317	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PRSS3—urinary bladder cancer	0.000192	0.00305	CbGpPWpGaD
Bleomycin—LIG1—Chromosome Maintenance—TERT—urinary bladder cancer	0.000187	0.00296	CbGpPWpGaD
Bleomycin—BLMH—Immune System—VHL—urinary bladder cancer	0.000184	0.00291	CbGpPWpGaD
Bleomycin—LIG1—S Phase—CCNE1—urinary bladder cancer	0.000182	0.00289	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—ERCC2—urinary bladder cancer	0.000178	0.00282	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—RBX1—urinary bladder cancer	0.000174	0.00276	CbGpPWpGaD
Bleomycin—LIG1—HIV Infection—RBX1—urinary bladder cancer	0.000173	0.00274	CbGpPWpGaD
Bleomycin—BLMH—Immune System—MT2A—urinary bladder cancer	0.000173	0.00274	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—ESPL1—urinary bladder cancer	0.000169	0.00267	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000161	0.00255	CbGpPWpGaD
Bleomycin—LIG1—HIV Life Cycle—ERCC2—urinary bladder cancer	0.000153	0.00243	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—ESPL1—urinary bladder cancer	0.000151	0.00239	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—ATM—urinary bladder cancer	0.00015	0.00238	CbGpPWpGaD
Bleomycin—LIG1—Synthesis of DNA—RB1—urinary bladder cancer	0.000148	0.00234	CbGpPWpGaD
Bleomycin—LIG1—S Phase—CDK4—urinary bladder cancer	0.00014	0.00221	CbGpPWpGaD
Bleomycin—LIG1—DNA Replication—RB1—urinary bladder cancer	0.000139	0.0022	CbGpPWpGaD
Bleomycin—BLMH—Immune System—BIRC3—urinary bladder cancer	0.000128	0.00204	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000128	0.00203	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—STAG2—urinary bladder cancer	0.000128	0.00203	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000126	0.00199	CbGpPWpGaD
Bleomycin—LIG1—S Phase—RB1—urinary bladder cancer	0.000121	0.00192	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—STAG2—urinary bladder cancer	0.000114	0.00181	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000112	0.00177	CbGpPWpGaD
Bleomycin—LIG1—Synthesis of DNA—CDKN1A—urinary bladder cancer	0.000106	0.00168	CbGpPWpGaD
Bleomycin—LIG1—HIV Infection—ERCC2—urinary bladder cancer	0.000106	0.00168	CbGpPWpGaD
Bleomycin—BLMH—Immune System—RBX1—urinary bladder cancer	0.000105	0.00167	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—RRM2—urinary bladder cancer	0.000105	0.00167	CbGpPWpGaD
Bleomycin—LIG1—Disease—GSTO2—urinary bladder cancer	0.000102	0.00162	CbGpPWpGaD
Bleomycin—LIG1—DNA Replication—CDKN1A—urinary bladder cancer	9.97e-05	0.00158	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	9.85e-05	0.00156	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	9.81e-05	0.00155	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	9.77e-05	0.00155	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—RRM2—urinary bladder cancer	9.41e-05	0.00149	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—FGFR3—urinary bladder cancer	9.17e-05	0.00145	CbGpPWpGaD
Bleomycin—LIG1—S Phase—CCND1—urinary bladder cancer	9.01e-05	0.00143	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—SMC1A—urinary bladder cancer	8.95e-05	0.00142	CbGpPWpGaD
Bleomycin—LIG1—S Phase—CDKN1A—urinary bladder cancer	8.72e-05	0.00138	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	8.56e-05	0.00136	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	8.46e-05	0.00134	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IFNA2—urinary bladder cancer	8.08e-05	0.00128	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—SMC1A—urinary bladder cancer	8e-05	0.00127	CbGpPWpGaD
Bleomycin—LIG1—Disease—SLC19A1—urinary bladder cancer	7.94e-05	0.00126	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CDH1—urinary bladder cancer	7.74e-05	0.00123	CbGpPWpGaD
Bleomycin—LIG1—Disease—PRSS3—urinary bladder cancer	7.74e-05	0.00123	CbGpPWpGaD
Bleomycin—BLMH—Immune System—S100B—urinary bladder cancer	7.64e-05	0.00121	CbGpPWpGaD
Bleomycin—LIG1—Disease—HDAC4—urinary bladder cancer	7.38e-05	0.00117	CbGpPWpGaD
Bleomycin—LIG1—S Phase—MYC—urinary bladder cancer	7.23e-05	0.00115	CbGpPWpGaD
Bleomycin—Anorexia—Thiotepa—urinary bladder cancer	7.22e-05	0.000942	CcSEcCtD
Bleomycin—Anaemia—Gemcitabine—urinary bladder cancer	7.22e-05	0.000941	CcSEcCtD
Bleomycin—Phlebitis—Epirubicin—urinary bladder cancer	7.21e-05	0.00094	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	7.17e-05	0.00114	CbGpPWpGaD
Bleomycin—Bladder pain—Doxorubicin—urinary bladder cancer	7.16e-05	0.000933	CcSEcCtD
Bleomycin—Flushing—Etoposide—urinary bladder cancer	7.11e-05	0.000927	CcSEcCtD
Bleomycin—Anaemia—Fluorouracil—urinary bladder cancer	7.1e-05	0.000925	CcSEcCtD
Bleomycin—Malaise—Gemcitabine—urinary bladder cancer	7.04e-05	0.000918	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	7.01e-05	0.00111	CbGpPWpGaD
Bleomycin—Leukopenia—Gemcitabine—urinary bladder cancer	6.99e-05	0.000912	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	6.9e-05	0.0009	CcSEcCtD
Bleomycin—Chills—Etoposide—urinary bladder cancer	6.88e-05	0.000896	CcSEcCtD
Bleomycin—Leukopenia—Fluorouracil—urinary bladder cancer	6.87e-05	0.000896	CcSEcCtD
Bleomycin—Cough—Gemcitabine—urinary bladder cancer	6.82e-05	0.000889	CcSEcCtD
Bleomycin—Paraesthesia—Thiotepa—urinary bladder cancer	6.81e-05	0.000887	CcSEcCtD
Bleomycin—Alopecia—Etoposide—urinary bladder cancer	6.77e-05	0.000883	CcSEcCtD
Bleomycin—Cerebrovascular accident—Methotrexate—urinary bladder cancer	6.77e-05	0.000883	CcSEcCtD
Bleomycin—Ill-defined disorder—Cisplatin—urinary bladder cancer	6.76e-05	0.000881	CcSEcCtD
Bleomycin—Anaemia—Cisplatin—urinary bladder cancer	6.73e-05	0.000877	CcSEcCtD
Bleomycin—Phlebitis—Doxorubicin—urinary bladder cancer	6.67e-05	0.000869	CcSEcCtD
Bleomycin—Myalgia—Gemcitabine—urinary bladder cancer	6.65e-05	0.000867	CcSEcCtD
Bleomycin—Chest pain—Gemcitabine—urinary bladder cancer	6.65e-05	0.000867	CcSEcCtD
Bleomycin—Decreased appetite—Thiotepa—urinary bladder cancer	6.59e-05	0.000859	CcSEcCtD
Bleomycin—Discomfort—Gemcitabine—urinary bladder cancer	6.57e-05	0.000857	CcSEcCtD
Bleomycin—Malaise—Cisplatin—urinary bladder cancer	6.57e-05	0.000856	CcSEcCtD
Bleomycin—Myalgia—Fluorouracil—urinary bladder cancer	6.54e-05	0.000852	CcSEcCtD
Bleomycin—Chest pain—Fluorouracil—urinary bladder cancer	6.54e-05	0.000852	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—ERBB2—urinary bladder cancer	6.53e-05	0.00104	CbGpPWpGaD
Bleomycin—Leukopenia—Cisplatin—urinary bladder cancer	6.52e-05	0.00085	CcSEcCtD
Bleomycin—Pain—Thiotepa—urinary bladder cancer	6.48e-05	0.000845	CcSEcCtD
Bleomycin—Discomfort—Fluorouracil—urinary bladder cancer	6.46e-05	0.000842	CcSEcCtD
Bleomycin—Oedema—Gemcitabine—urinary bladder cancer	6.38e-05	0.000831	CcSEcCtD
Bleomycin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	6.38e-05	0.000831	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	6.34e-05	0.001	CbGpPWpGaD
Bleomycin—Cerebrovascular accident—Epirubicin—urinary bladder cancer	6.34e-05	0.000826	CcSEcCtD
Bleomycin—Infection—Gemcitabine—urinary bladder cancer	6.33e-05	0.000826	CcSEcCtD
Bleomycin—Confusional state—Fluorouracil—urinary bladder cancer	6.32e-05	0.000824	CcSEcCtD
Bleomycin—Oedema—Fluorouracil—urinary bladder cancer	6.27e-05	0.000817	CcSEcCtD
Bleomycin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	6.27e-05	0.000817	CcSEcCtD
Bleomycin—Feeling abnormal—Thiotepa—urinary bladder cancer	6.25e-05	0.000814	CcSEcCtD
Bleomycin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	6.24e-05	0.000814	CcSEcCtD
Bleomycin—Infection—Fluorouracil—urinary bladder cancer	6.23e-05	0.000812	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	6.2e-05	0.000983	CbGpPWpGaD
Bleomycin—Myalgia—Cisplatin—urinary bladder cancer	6.2e-05	0.000808	CcSEcCtD
Bleomycin—Ill-defined disorder—Etoposide—urinary bladder cancer	6.19e-05	0.000807	CcSEcCtD
Bleomycin—Anaemia—Etoposide—urinary bladder cancer	6.17e-05	0.000804	CcSEcCtD
Bleomycin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	6.14e-05	0.0008	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	6.13e-05	0.000971	CbGpPWpGaD
Bleomycin—Discomfort—Cisplatin—urinary bladder cancer	6.12e-05	0.000798	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	6.12e-05	0.000969	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	6.09e-05	0.000965	CbGpPWpGaD
Bleomycin—Anorexia—Gemcitabine—urinary bladder cancer	6.08e-05	0.000792	CcSEcCtD
Bleomycin—Urticaria—Thiotepa—urinary bladder cancer	6.02e-05	0.000785	CcSEcCtD
Bleomycin—Malaise—Etoposide—urinary bladder cancer	6.02e-05	0.000784	CcSEcCtD
Bleomycin—Body temperature increased—Thiotepa—urinary bladder cancer	5.99e-05	0.000781	CcSEcCtD
Bleomycin—Anorexia—Fluorouracil—urinary bladder cancer	5.98e-05	0.000779	CcSEcCtD
Bleomycin—Leukopenia—Etoposide—urinary bladder cancer	5.97e-05	0.000778	CcSEcCtD
Bleomycin—Hypotension—Gemcitabine—urinary bladder cancer	5.96e-05	0.000777	CcSEcCtD
Bleomycin—Oedema—Cisplatin—urinary bladder cancer	5.94e-05	0.000775	CcSEcCtD
Bleomycin—Anaphylactic shock—Cisplatin—urinary bladder cancer	5.94e-05	0.000775	CcSEcCtD
Bleomycin—Infection—Cisplatin—urinary bladder cancer	5.9e-05	0.00077	CcSEcCtD
Bleomycin—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	5.86e-05	0.000764	CcSEcCtD
Bleomycin—Hypotension—Fluorouracil—urinary bladder cancer	5.86e-05	0.000764	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	5.83e-05	0.000924	CbGpPWpGaD
Bleomycin—Cough—Etoposide—urinary bladder cancer	5.82e-05	0.000759	CcSEcCtD
Bleomycin—Thrombocytopenia—Cisplatin—urinary bladder cancer	5.82e-05	0.000758	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	5.81e-05	0.000757	CcSEcCtD
Bleomycin—Paraesthesia—Gemcitabine—urinary bladder cancer	5.72e-05	0.000746	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	5.71e-05	0.000744	CcSEcCtD
Bleomycin—Dyspnoea—Gemcitabine—urinary bladder cancer	5.68e-05	0.000741	CcSEcCtD
Bleomycin—Chest pain—Etoposide—urinary bladder cancer	5.68e-05	0.00074	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	5.67e-05	0.000899	CbGpPWpGaD
Bleomycin—Anorexia—Cisplatin—urinary bladder cancer	5.66e-05	0.000738	CcSEcCtD
Bleomycin—Paraesthesia—Fluorouracil—urinary bladder cancer	5.63e-05	0.000734	CcSEcCtD
Bleomycin—Discomfort—Etoposide—urinary bladder cancer	5.61e-05	0.000731	CcSEcCtD
Bleomycin—Dyspnoea—Fluorouracil—urinary bladder cancer	5.59e-05	0.000729	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—CDKN1A—urinary bladder cancer	5.58e-05	0.000885	CbGpPWpGaD
Bleomycin—Hypersensitivity—Thiotepa—urinary bladder cancer	5.58e-05	0.000728	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—PTEN—urinary bladder cancer	5.57e-05	0.000883	CbGpPWpGaD
Bleomycin—BLMH—Immune System—FGFR3—urinary bladder cancer	5.56e-05	0.000881	CbGpPWpGaD
Bleomycin—Hypotension—Cisplatin—urinary bladder cancer	5.55e-05	0.000724	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CCNE1—urinary bladder cancer	5.55e-05	0.000879	CbGpPWpGaD
Bleomycin—Decreased appetite—Gemcitabine—urinary bladder cancer	5.54e-05	0.000722	CcSEcCtD
Bleomycin—Confusional state—Etoposide—urinary bladder cancer	5.49e-05	0.000716	CcSEcCtD
Bleomycin—Pain—Gemcitabine—urinary bladder cancer	5.45e-05	0.000711	CcSEcCtD
Bleomycin—Decreased appetite—Fluorouracil—urinary bladder cancer	5.45e-05	0.00071	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—TYMS—urinary bladder cancer	5.45e-05	0.000863	CbGpPWpGaD
Bleomycin—Pancytopenia—Methotrexate—urinary bladder cancer	5.45e-05	0.00071	CcSEcCtD
Bleomycin—Anaphylactic shock—Etoposide—urinary bladder cancer	5.44e-05	0.00071	CcSEcCtD
Bleomycin—Asthenia—Thiotepa—urinary bladder cancer	5.44e-05	0.000709	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	5.41e-05	0.000706	CcSEcCtD
Bleomycin—Infection—Etoposide—urinary bladder cancer	5.41e-05	0.000705	CcSEcCtD
Bleomycin—Pruritus—Thiotepa—urinary bladder cancer	5.36e-05	0.000699	CcSEcCtD
Bleomycin—Pain—Fluorouracil—urinary bladder cancer	5.36e-05	0.000699	CcSEcCtD
Bleomycin—Paraesthesia—Cisplatin—urinary bladder cancer	5.34e-05	0.000696	CcSEcCtD
Bleomycin—Thrombocytopenia—Etoposide—urinary bladder cancer	5.33e-05	0.000695	CcSEcCtD
Bleomycin—Dyspnoea—Cisplatin—urinary bladder cancer	5.3e-05	0.000691	CcSEcCtD
Bleomycin—Feeling abnormal—Gemcitabine—urinary bladder cancer	5.25e-05	0.000685	CcSEcCtD
Bleomycin—Anorexia—Etoposide—urinary bladder cancer	5.19e-05	0.000676	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—SRC—urinary bladder cancer	5.17e-05	0.000819	CbGpPWpGaD
Bleomycin—Decreased appetite—Cisplatin—urinary bladder cancer	5.17e-05	0.000673	CcSEcCtD
Bleomycin—Feeling abnormal—Fluorouracil—urinary bladder cancer	5.17e-05	0.000673	CcSEcCtD
Bleomycin—Pneumonia—Methotrexate—urinary bladder cancer	5.14e-05	0.00067	CcSEcCtD
Bleomycin—Pancytopenia—Epirubicin—urinary bladder cancer	5.1e-05	0.000664	CcSEcCtD
Bleomycin—Hypotension—Etoposide—urinary bladder cancer	5.09e-05	0.000663	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	5.08e-05	0.000805	CbGpPWpGaD
Bleomycin—Pain—Cisplatin—urinary bladder cancer	5.08e-05	0.000662	CcSEcCtD
Bleomycin—Body temperature increased—Gemcitabine—urinary bladder cancer	5.04e-05	0.000657	CcSEcCtD
Bleomycin—Stomatitis—Methotrexate—urinary bladder cancer	4.98e-05	0.00065	CcSEcCtD
Bleomycin—Urticaria—Fluorouracil—urinary bladder cancer	4.98e-05	0.000649	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	4.97e-05	0.000788	CbGpPWpGaD
Bleomycin—Body temperature increased—Fluorouracil—urinary bladder cancer	4.96e-05	0.000646	CcSEcCtD
Bleomycin—Feeling abnormal—Cisplatin—urinary bladder cancer	4.9e-05	0.000638	CcSEcCtD
Bleomycin—Paraesthesia—Etoposide—urinary bladder cancer	4.89e-05	0.000637	CcSEcCtD
Bleomycin—Haematuria—Methotrexate—urinary bladder cancer	4.87e-05	0.000635	CcSEcCtD
Bleomycin—Weight decreased—Epirubicin—urinary bladder cancer	4.85e-05	0.000633	CcSEcCtD
Bleomycin—Dyspnoea—Etoposide—urinary bladder cancer	4.85e-05	0.000633	CcSEcCtD
Bleomycin—Vomiting—Thiotepa—urinary bladder cancer	4.82e-05	0.000628	CcSEcCtD
Bleomycin—Pneumonia—Epirubicin—urinary bladder cancer	4.81e-05	0.000627	CcSEcCtD
Bleomycin—Rash—Thiotepa—urinary bladder cancer	4.78e-05	0.000623	CcSEcCtD
Bleomycin—Dermatitis—Thiotepa—urinary bladder cancer	4.77e-05	0.000622	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	4.75e-05	0.000753	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TERT—urinary bladder cancer	4.75e-05	0.000752	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	4.73e-05	0.00075	CbGpPWpGaD
Bleomycin—Decreased appetite—Etoposide—urinary bladder cancer	4.73e-05	0.000617	CcSEcCtD
Bleomycin—BLMH—Immune System—CREBBP—urinary bladder cancer	4.73e-05	0.00075	CbGpPWpGaD
Bleomycin—Pancytopenia—Doxorubicin—urinary bladder cancer	4.72e-05	0.000615	CcSEcCtD
Bleomycin—Body temperature increased—Cisplatin—urinary bladder cancer	4.7e-05	0.000612	CcSEcCtD
Bleomycin—BLMH—Immune System—CDH1—urinary bladder cancer	4.7e-05	0.000744	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	4.7e-05	0.000744	CbGpPWpGaD
Bleomycin—Stomatitis—Epirubicin—urinary bladder cancer	4.66e-05	0.000608	CcSEcCtD
Bleomycin—Pain—Etoposide—urinary bladder cancer	4.66e-05	0.000607	CcSEcCtD
Bleomycin—Hypersensitivity—Fluorouracil—urinary bladder cancer	4.62e-05	0.000602	CcSEcCtD
Bleomycin—Haemoglobin—Methotrexate—urinary bladder cancer	4.61e-05	0.000601	CcSEcCtD
Bleomycin—Haemorrhage—Methotrexate—urinary bladder cancer	4.59e-05	0.000598	CcSEcCtD
Bleomycin—Asthenia—Gemcitabine—urinary bladder cancer	4.57e-05	0.000596	CcSEcCtD
Bleomycin—Haematuria—Epirubicin—urinary bladder cancer	4.56e-05	0.000595	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—EGFR—urinary bladder cancer	4.53e-05	0.000718	CbGpPWpGaD
Bleomycin—Pruritus—Gemcitabine—urinary bladder cancer	4.51e-05	0.000588	CcSEcCtD
Bleomycin—Nausea—Thiotepa—urinary bladder cancer	4.5e-05	0.000587	CcSEcCtD
Bleomycin—Weight decreased—Doxorubicin—urinary bladder cancer	4.49e-05	0.000586	CcSEcCtD
Bleomycin—Feeling abnormal—Etoposide—urinary bladder cancer	4.49e-05	0.000585	CcSEcCtD
Bleomycin—LIG1—Disease—ENO2—urinary bladder cancer	4.47e-05	0.000709	CbGpPWpGaD
Bleomycin—Pneumonia—Doxorubicin—urinary bladder cancer	4.45e-05	0.00058	CcSEcCtD
Bleomycin—Pruritus—Fluorouracil—urinary bladder cancer	4.43e-05	0.000578	CcSEcCtD
Bleomycin—Hypersensitivity—Cisplatin—urinary bladder cancer	4.38e-05	0.000571	CcSEcCtD
Bleomycin—Urticaria—Etoposide—urinary bladder cancer	4.32e-05	0.000564	CcSEcCtD
Bleomycin—Haemoglobin—Epirubicin—urinary bladder cancer	4.32e-05	0.000563	CcSEcCtD
Bleomycin—Stomatitis—Doxorubicin—urinary bladder cancer	4.32e-05	0.000563	CcSEcCtD
Bleomycin—Body temperature increased—Etoposide—urinary bladder cancer	4.3e-05	0.000561	CcSEcCtD
Bleomycin—Haemorrhage—Epirubicin—urinary bladder cancer	4.3e-05	0.00056	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—KRAS—urinary bladder cancer	4.28e-05	0.000678	CbGpPWpGaD
Bleomycin—Hypoaesthesia—Epirubicin—urinary bladder cancer	4.27e-05	0.000557	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—ATM—urinary bladder cancer	4.27e-05	0.000676	CbGpPWpGaD
Bleomycin—Asthenia—Cisplatin—urinary bladder cancer	4.26e-05	0.000556	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CDK4—urinary bladder cancer	4.25e-05	0.000673	CbGpPWpGaD
Bleomycin—LIG1—Disease—RBX1—urinary bladder cancer	4.24e-05	0.000672	CbGpPWpGaD
Bleomycin—Haematuria—Doxorubicin—urinary bladder cancer	4.22e-05	0.00055	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	4.17e-05	0.000661	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—RB1—urinary bladder cancer	4.13e-05	0.000655	CbGpPWpGaD
Bleomycin—Chills—Methotrexate—urinary bladder cancer	4.12e-05	0.000537	CcSEcCtD
Bleomycin—Alopecia—Methotrexate—urinary bladder cancer	4.06e-05	0.000529	CcSEcCtD
Bleomycin—Vomiting—Gemcitabine—urinary bladder cancer	4.05e-05	0.000528	CcSEcCtD
Bleomycin—Rash—Gemcitabine—urinary bladder cancer	4.02e-05	0.000524	CcSEcCtD
Bleomycin—Dermatitis—Gemcitabine—urinary bladder cancer	4.02e-05	0.000524	CcSEcCtD
Bleomycin—Hypersensitivity—Etoposide—urinary bladder cancer	4.01e-05	0.000523	CcSEcCtD
Bleomycin—Erythema—Methotrexate—urinary bladder cancer	4e-05	0.000521	CcSEcCtD
Bleomycin—Haemoglobin—Doxorubicin—urinary bladder cancer	3.99e-05	0.000521	CcSEcCtD
Bleomycin—Flushing—Epirubicin—urinary bladder cancer	3.99e-05	0.00052	CcSEcCtD
Bleomycin—Vomiting—Fluorouracil—urinary bladder cancer	3.99e-05	0.00052	CcSEcCtD
Bleomycin—Haemorrhage—Doxorubicin—urinary bladder cancer	3.97e-05	0.000518	CcSEcCtD
Bleomycin—BLMH—Immune System—ERBB2—urinary bladder cancer	3.96e-05	0.000628	CbGpPWpGaD
Bleomycin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	3.95e-05	0.000516	CcSEcCtD
Bleomycin—Rash—Fluorouracil—urinary bladder cancer	3.95e-05	0.000515	CcSEcCtD
Bleomycin—Dermatitis—Fluorouracil—urinary bladder cancer	3.95e-05	0.000515	CcSEcCtD
Bleomycin—Asthenia—Etoposide—urinary bladder cancer	3.91e-05	0.000509	CcSEcCtD
Bleomycin—Chills—Epirubicin—urinary bladder cancer	3.85e-05	0.000502	CcSEcCtD
Bleomycin—Pruritus—Etoposide—urinary bladder cancer	3.85e-05	0.000502	CcSEcCtD
Bleomycin—Alopecia—Epirubicin—urinary bladder cancer	3.8e-05	0.000495	CcSEcCtD
Bleomycin—LIG1—Disease—JAG1—urinary bladder cancer	3.79e-05	0.000601	CbGpPWpGaD
Bleomycin—Nausea—Gemcitabine—urinary bladder cancer	3.79e-05	0.000494	CcSEcCtD
Bleomycin—Vomiting—Cisplatin—urinary bladder cancer	3.78e-05	0.000493	CcSEcCtD
Bleomycin—Rash—Cisplatin—urinary bladder cancer	3.75e-05	0.000488	CcSEcCtD
Bleomycin—Dermatitis—Cisplatin—urinary bladder cancer	3.74e-05	0.000488	CcSEcCtD
Bleomycin—Erythema—Epirubicin—urinary bladder cancer	3.74e-05	0.000487	CcSEcCtD
Bleomycin—Nausea—Fluorouracil—urinary bladder cancer	3.72e-05	0.000485	CcSEcCtD
Bleomycin—Ill-defined disorder—Methotrexate—urinary bladder cancer	3.71e-05	0.000483	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—RB1—urinary bladder cancer	3.69e-05	0.000585	CbGpPWpGaD
Bleomycin—Anaemia—Methotrexate—urinary bladder cancer	3.69e-05	0.000481	CcSEcCtD
Bleomycin—Flushing—Doxorubicin—urinary bladder cancer	3.69e-05	0.000481	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—HRAS—urinary bladder cancer	3.64e-05	0.000576	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	3.63e-05	0.000575	CbGpPWpGaD
Bleomycin—Malaise—Methotrexate—urinary bladder cancer	3.6e-05	0.00047	CcSEcCtD
Bleomycin—BLMH—Immune System—IL2—urinary bladder cancer	3.59e-05	0.000569	CbGpPWpGaD
Bleomycin—Leukopenia—Methotrexate—urinary bladder cancer	3.58e-05	0.000466	CcSEcCtD
Bleomycin—Chills—Doxorubicin—urinary bladder cancer	3.57e-05	0.000465	CcSEcCtD
Bleomycin—Nausea—Cisplatin—urinary bladder cancer	3.53e-05	0.00046	CcSEcCtD
Bleomycin—Alopecia—Doxorubicin—urinary bladder cancer	3.51e-05	0.000458	CcSEcCtD
Bleomycin—Cough—Methotrexate—urinary bladder cancer	3.49e-05	0.000455	CcSEcCtD
Bleomycin—Ill-defined disorder—Epirubicin—urinary bladder cancer	3.47e-05	0.000452	CcSEcCtD
Bleomycin—Vomiting—Etoposide—urinary bladder cancer	3.46e-05	0.000451	CcSEcCtD
Bleomycin—Erythema—Doxorubicin—urinary bladder cancer	3.46e-05	0.000451	CcSEcCtD
Bleomycin—Anaemia—Epirubicin—urinary bladder cancer	3.46e-05	0.000451	CcSEcCtD
Bleomycin—Rash—Etoposide—urinary bladder cancer	3.43e-05	0.000447	CcSEcCtD
Bleomycin—Dermatitis—Etoposide—urinary bladder cancer	3.43e-05	0.000447	CcSEcCtD
Bleomycin—Myalgia—Methotrexate—urinary bladder cancer	3.4e-05	0.000443	CcSEcCtD
Bleomycin—Chest pain—Methotrexate—urinary bladder cancer	3.4e-05	0.000443	CcSEcCtD
Bleomycin—BLMH—Immune System—CDKN1A—urinary bladder cancer	3.39e-05	0.000537	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PTEN—urinary bladder cancer	3.38e-05	0.000536	CbGpPWpGaD
Bleomycin—Malaise—Epirubicin—urinary bladder cancer	3.37e-05	0.00044	CcSEcCtD
Bleomycin—Discomfort—Methotrexate—urinary bladder cancer	3.36e-05	0.000438	CcSEcCtD
Bleomycin—Leukopenia—Epirubicin—urinary bladder cancer	3.35e-05	0.000436	CcSEcCtD
Bleomycin—Confusional state—Methotrexate—urinary bladder cancer	3.29e-05	0.000429	CcSEcCtD
Bleomycin—Cough—Epirubicin—urinary bladder cancer	3.26e-05	0.000425	CcSEcCtD
Bleomycin—Anaphylactic shock—Methotrexate—urinary bladder cancer	3.26e-05	0.000425	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CDKN2A—urinary bladder cancer	3.25e-05	0.000514	CbGpPWpGaD
Bleomycin—Infection—Methotrexate—urinary bladder cancer	3.24e-05	0.000422	CcSEcCtD
Bleomycin—Nausea—Etoposide—urinary bladder cancer	3.23e-05	0.000422	CcSEcCtD
Bleomycin—BLMH—Immune System—EP300—urinary bladder cancer	3.22e-05	0.000511	CbGpPWpGaD
Bleomycin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	3.21e-05	0.000418	CcSEcCtD
Bleomycin—Anaemia—Doxorubicin—urinary bladder cancer	3.2e-05	0.000417	CcSEcCtD
Bleomycin—Thrombocytopenia—Methotrexate—urinary bladder cancer	3.19e-05	0.000416	CcSEcCtD
Bleomycin—Myalgia—Epirubicin—urinary bladder cancer	3.18e-05	0.000415	CcSEcCtD
Bleomycin—Chest pain—Epirubicin—urinary bladder cancer	3.18e-05	0.000415	CcSEcCtD
Bleomycin—Discomfort—Epirubicin—urinary bladder cancer	3.15e-05	0.00041	CcSEcCtD
Bleomycin—BLMH—Immune System—SRC—urinary bladder cancer	3.13e-05	0.000497	CbGpPWpGaD
Bleomycin—Malaise—Doxorubicin—urinary bladder cancer	3.12e-05	0.000407	CcSEcCtD
Bleomycin—Anorexia—Methotrexate—urinary bladder cancer	3.11e-05	0.000405	CcSEcCtD
Bleomycin—Leukopenia—Doxorubicin—urinary bladder cancer	3.1e-05	0.000404	CcSEcCtD
Bleomycin—Confusional state—Epirubicin—urinary bladder cancer	3.08e-05	0.000401	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	3.07e-05	0.000486	CbGpPWpGaD
Bleomycin—Oedema—Epirubicin—urinary bladder cancer	3.05e-05	0.000398	CcSEcCtD
Bleomycin—Anaphylactic shock—Epirubicin—urinary bladder cancer	3.05e-05	0.000398	CcSEcCtD
Bleomycin—Hypotension—Methotrexate—urinary bladder cancer	3.05e-05	0.000397	CcSEcCtD
Bleomycin—Infection—Epirubicin—urinary bladder cancer	3.03e-05	0.000395	CcSEcCtD
Bleomycin—Cough—Doxorubicin—urinary bladder cancer	3.02e-05	0.000394	CcSEcCtD
Bleomycin—Thrombocytopenia—Epirubicin—urinary bladder cancer	2.99e-05	0.00039	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	2.97e-05	0.000387	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	2.97e-05	0.00047	CbGpPWpGaD
Bleomycin—Myalgia—Doxorubicin—urinary bladder cancer	2.95e-05	0.000384	CcSEcCtD
Bleomycin—Chest pain—Doxorubicin—urinary bladder cancer	2.95e-05	0.000384	CcSEcCtD
Bleomycin—Paraesthesia—Methotrexate—urinary bladder cancer	2.93e-05	0.000382	CcSEcCtD
Bleomycin—Discomfort—Doxorubicin—urinary bladder cancer	2.91e-05	0.000379	CcSEcCtD
Bleomycin—Anorexia—Epirubicin—urinary bladder cancer	2.91e-05	0.000379	CcSEcCtD
Bleomycin—Dyspnoea—Methotrexate—urinary bladder cancer	2.91e-05	0.000379	CcSEcCtD
Bleomycin—Hypotension—Epirubicin—urinary bladder cancer	2.85e-05	0.000372	CcSEcCtD
Bleomycin—Confusional state—Doxorubicin—urinary bladder cancer	2.85e-05	0.000371	CcSEcCtD
Bleomycin—Decreased appetite—Methotrexate—urinary bladder cancer	2.83e-05	0.00037	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—EP300—urinary bladder cancer	2.82e-05	0.000447	CbGpPWpGaD
Bleomycin—Oedema—Doxorubicin—urinary bladder cancer	2.82e-05	0.000368	CcSEcCtD
Bleomycin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	2.82e-05	0.000368	CcSEcCtD
Bleomycin—Infection—Doxorubicin—urinary bladder cancer	2.81e-05	0.000366	CcSEcCtD
Bleomycin—Pain—Methotrexate—urinary bladder cancer	2.79e-05	0.000364	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	2.78e-05	0.000362	CcSEcCtD
Bleomycin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	2.76e-05	0.00036	CcSEcCtD
Bleomycin—LIG1—Disease—NCOR1—urinary bladder cancer	2.76e-05	0.000438	CbGpPWpGaD
Bleomycin—BLMH—Immune System—EGFR—urinary bladder cancer	2.75e-05	0.000435	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CCND1—urinary bladder cancer	2.74e-05	0.000435	CbGpPWpGaD
Bleomycin—Paraesthesia—Epirubicin—urinary bladder cancer	2.74e-05	0.000357	CcSEcCtD
Bleomycin—Dyspnoea—Epirubicin—urinary bladder cancer	2.72e-05	0.000355	CcSEcCtD
Bleomycin—Anorexia—Doxorubicin—urinary bladder cancer	2.69e-05	0.000351	CcSEcCtD
Bleomycin—Feeling abnormal—Methotrexate—urinary bladder cancer	2.69e-05	0.00035	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CDKN1A—urinary bladder cancer	2.65e-05	0.00042	CbGpPWpGaD
Bleomycin—Decreased appetite—Epirubicin—urinary bladder cancer	2.65e-05	0.000346	CcSEcCtD
Bleomycin—Hypotension—Doxorubicin—urinary bladder cancer	2.64e-05	0.000344	CcSEcCtD
Bleomycin—Pain—Epirubicin—urinary bladder cancer	2.61e-05	0.00034	CcSEcCtD
Bleomycin—LIG1—Disease—ERCC2—urinary bladder cancer	2.6e-05	0.000412	CbGpPWpGaD
Bleomycin—BLMH—Immune System—KRAS—urinary bladder cancer	2.59e-05	0.000411	CbGpPWpGaD
Bleomycin—Urticaria—Methotrexate—urinary bladder cancer	2.59e-05	0.000338	CcSEcCtD
Bleomycin—Body temperature increased—Methotrexate—urinary bladder cancer	2.58e-05	0.000336	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	2.57e-05	0.000335	CcSEcCtD
Bleomycin—Paraesthesia—Doxorubicin—urinary bladder cancer	2.54e-05	0.000331	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—EP300—urinary bladder cancer	2.52e-05	0.0004	CbGpPWpGaD
Bleomycin—Dyspnoea—Doxorubicin—urinary bladder cancer	2.52e-05	0.000328	CcSEcCtD
Bleomycin—Feeling abnormal—Epirubicin—urinary bladder cancer	2.51e-05	0.000328	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—MYC—urinary bladder cancer	2.46e-05	0.00039	CbGpPWpGaD
Bleomycin—Decreased appetite—Doxorubicin—urinary bladder cancer	2.45e-05	0.00032	CcSEcCtD
Bleomycin—LIG1—Disease—MTHFR—urinary bladder cancer	2.44e-05	0.000387	CbGpPWpGaD
Bleomycin—LIG1—Disease—TERT—urinary bladder cancer	2.43e-05	0.000386	CbGpPWpGaD
Bleomycin—Urticaria—Epirubicin—urinary bladder cancer	2.42e-05	0.000316	CcSEcCtD
Bleomycin—Pain—Doxorubicin—urinary bladder cancer	2.41e-05	0.000315	CcSEcCtD
Bleomycin—Body temperature increased—Epirubicin—urinary bladder cancer	2.41e-05	0.000314	CcSEcCtD
Bleomycin—Hypersensitivity—Methotrexate—urinary bladder cancer	2.4e-05	0.000313	CcSEcCtD
Bleomycin—Asthenia—Methotrexate—urinary bladder cancer	2.34e-05	0.000305	CcSEcCtD
Bleomycin—Feeling abnormal—Doxorubicin—urinary bladder cancer	2.33e-05	0.000303	CcSEcCtD
Bleomycin—Pruritus—Methotrexate—urinary bladder cancer	2.31e-05	0.000301	CcSEcCtD
Bleomycin—Hypersensitivity—Epirubicin—urinary bladder cancer	2.25e-05	0.000293	CcSEcCtD
Bleomycin—Urticaria—Doxorubicin—urinary bladder cancer	2.24e-05	0.000292	CcSEcCtD
Bleomycin—LIG1—Disease—FGFR3—urinary bladder cancer	2.23e-05	0.000354	CbGpPWpGaD
Bleomycin—Body temperature increased—Doxorubicin—urinary bladder cancer	2.23e-05	0.000291	CcSEcCtD
Bleomycin—BLMH—Immune System—HRAS—urinary bladder cancer	2.21e-05	0.00035	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—MYC—urinary bladder cancer	2.2e-05	0.000349	CbGpPWpGaD
Bleomycin—Asthenia—Epirubicin—urinary bladder cancer	2.19e-05	0.000285	CcSEcCtD
Bleomycin—Pruritus—Epirubicin—urinary bladder cancer	2.16e-05	0.000281	CcSEcCtD
Bleomycin—Hypersensitivity—Doxorubicin—urinary bladder cancer	2.08e-05	0.000271	CcSEcCtD
Bleomycin—Vomiting—Methotrexate—urinary bladder cancer	2.07e-05	0.00027	CcSEcCtD
Bleomycin—Rash—Methotrexate—urinary bladder cancer	2.06e-05	0.000268	CcSEcCtD
Bleomycin—Dermatitis—Methotrexate—urinary bladder cancer	2.05e-05	0.000268	CcSEcCtD
Bleomycin—Asthenia—Doxorubicin—urinary bladder cancer	2.03e-05	0.000264	CcSEcCtD
Bleomycin—Pruritus—Doxorubicin—urinary bladder cancer	2e-05	0.00026	CcSEcCtD
Bleomycin—Vomiting—Epirubicin—urinary bladder cancer	1.94e-05	0.000253	CcSEcCtD
Bleomycin—Nausea—Methotrexate—urinary bladder cancer	1.94e-05	0.000252	CcSEcCtD
Bleomycin—Rash—Epirubicin—urinary bladder cancer	1.92e-05	0.000251	CcSEcCtD
Bleomycin—Dermatitis—Epirubicin—urinary bladder cancer	1.92e-05	0.000251	CcSEcCtD
Bleomycin—LIG1—Disease—CREBBP—urinary bladder cancer	1.9e-05	0.000301	CbGpPWpGaD
Bleomycin—Nausea—Epirubicin—urinary bladder cancer	1.81e-05	0.000236	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—TP53—urinary bladder cancer	1.81e-05	0.000286	CbGpPWpGaD
Bleomycin—Vomiting—Doxorubicin—urinary bladder cancer	1.8e-05	0.000234	CcSEcCtD
Bleomycin—Rash—Doxorubicin—urinary bladder cancer	1.78e-05	0.000232	CcSEcCtD
Bleomycin—Dermatitis—Doxorubicin—urinary bladder cancer	1.78e-05	0.000232	CcSEcCtD
Bleomycin—LIG1—Disease—RHOA—urinary bladder cancer	1.72e-05	0.000273	CbGpPWpGaD
Bleomycin—Nausea—Doxorubicin—urinary bladder cancer	1.68e-05	0.000219	CcSEcCtD
Bleomycin—LIG1—Disease—ERBB2—urinary bladder cancer	1.59e-05	0.000252	CbGpPWpGaD
Bleomycin—LIG1—Disease—PTGS2—urinary bladder cancer	1.56e-05	0.000247	CbGpPWpGaD
Bleomycin—LIG1—Disease—CDKN1A—urinary bladder cancer	1.36e-05	0.000216	CbGpPWpGaD
Bleomycin—LIG1—Disease—PTEN—urinary bladder cancer	1.36e-05	0.000215	CbGpPWpGaD
Bleomycin—LIG1—Disease—EP300—urinary bladder cancer	1.3e-05	0.000205	CbGpPWpGaD
Bleomycin—LIG1—Disease—SRC—urinary bladder cancer	1.26e-05	0.0002	CbGpPWpGaD
Bleomycin—LIG1—Disease—MYC—urinary bladder cancer	1.13e-05	0.000179	CbGpPWpGaD
Bleomycin—LIG1—Disease—EGFR—urinary bladder cancer	1.1e-05	0.000175	CbGpPWpGaD
Bleomycin—LIG1—Disease—KRAS—urinary bladder cancer	1.04e-05	0.000165	CbGpPWpGaD
Bleomycin—LIG1—Disease—HRAS—urinary bladder cancer	8.86e-06	0.00014	CbGpPWpGaD
